IRIS
MURINEDDU, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.672
EU - Europa 1.500
AS - Asia 850
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 8
AF - Africa 6
AN - Antartide 1
Totale 5.059
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.659
UA - Ucraina 673
CN - Cina 639
DE - Germania 237
IT - Italia 173
SE - Svezia 137
FI - Finlandia 108
SG - Singapore 90
TR - Turchia 79
GB - Regno Unito 54
FR - Francia 43
BE - Belgio 30
KR - Corea 15
CZ - Repubblica Ceca 13
AU - Australia 12
CA - Canada 11
EU - Europa 8
IN - India 8
IR - Iran 8
RO - Romania 7
BR - Brasile 5
ES - Italia 4
EG - Egitto 3
JP - Giappone 3
BG - Bulgaria 2
DK - Danimarca 2
HU - Ungheria 2
IQ - Iraq 2
NL - Olanda 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BD - Bangladesh 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
DZ - Algeria 1
GS - Georgia del Sud e Isole Sandwich Australi 1
IL - Israele 1
JM - Giamaica 1
MC - Monaco 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TH - Thailandia 1
VG - Isole Vergini Britanniche 1
ZA - Sudafrica 1
Totale 5.059
Salva come PNG Salva come JPEG
Città #
Chandler 675
Jacksonville 417
Princeton 238
Dearborn 216
Nanjing 192
Ann Arbor 109
Wilmington 105
New York 81
Izmir 76
Sassari 61
Ashburn 58
Nanchang 56
Shenyang 56
Beijing 52
Woodbridge 46
Hebei 43
Singapore 41
Changsha 38
Brussels 29
Jiaxing 29
Tianjin 29
Kunming 22
Boardman 21
Andover 19
Ningbo 19
Jinan 17
San Mateo 17
Hangzhou 16
Mountain View 16
Norwalk 16
Seoul 15
Guangzhou 14
San Francisco 13
Helsinki 12
Taizhou 12
Monmouth Junction 11
Zhengzhou 11
Augusta 9
Brno 9
Dallas 9
Rome 9
Toronto 9
Auburn Hills 8
Lanzhou 8
Albissola Marina 7
Leawood 7
Edinburgh 6
Los Angeles 6
Quartu Sant'Elena 6
Hanover 5
Horia 5
London 5
Melbourne 5
Ardabil 4
Changchun 4
Frankfurt am Main 4
Houston 4
Munich 4
São Paulo 4
Alghero 3
Haikou 3
Olomouc 3
Paris 3
Tokyo 3
Aversa 2
Bariano 2
Budapest 2
Canberra 2
Castel Gandolfo 2
Fuzhou 2
Genoa 2
Hefei 2
Huskvarna 2
Incisa 2
Media 2
Montreal 2
Mumbai 2
Nutley 2
Palermo 2
Quartucciu 2
Seattle 2
Sofia 2
Aarau 1
Abuja 1
Algiers 1
Amsterdam 1
Atlanta 1
Baghdad 1
Bangalore 1
Bangkok 1
Baotou 1
Belgrade 1
Berlin 1
Bologna 1
Bratislava 1
Brierley Hill 1
Cagliari 1
Chengdu 1
Chisinau 1
Cleveland 1
Totale 3.104
Salva come PNG Salva come JPEG
Nome #
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors 80
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties. 78
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2 ',4 '-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyra zole-3-carboxamide 69
Synthesis and D2-like binding affinity of new derivatives of N-(1-ethyl-2-pyrrolidinylmethyl)-4,5-dihydro-1H-benzo[g]indole-3-carboxamide and related 4H-[1]Benzothiopyrano[4,3-b]pyrrole and 5,6-Dihydro-4H benzo[6,7]cyclohepta[b]pyrrole-3-carboxamide Analogues 67
Chiral pyridine N-oxides useful ligands for asymmetric catalysis 67
Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems 65
Chromophore-modified bis-benzo[g]indazole carboxamides: synthesis and antiproliferactive activity of bis-benzo[g]indazole carboxamides and related dimers 65
Approcci terapeutici contro il cancro. Tradizione e innovazione. 65
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists 64
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors 63
Chemistry of tricyclic-based heterocycles as useful scaffolds for phosphodiesterase 10A ligands 62
The organic chemistry of drug design and drug action 62
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 60
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 60
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism 60
Correction to Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles 60
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6- tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives. 59
Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors 58
Composti farmaceutici 58
An overview on different classes of viral entry and respiratory syncitial virus (RSV) fusion inhibitors 56
Synthesis, Modelling, and Antimitotic Properties of Tricyclic Systems Characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole Moiety 56
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 56
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking 55
Pyrazole derivatives having affinity for CB1 and/or CB2 receptors 54
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 54
CAPITOLO 41. Antielmintici 54
Design, Synthesis and preliminary biological data of new ligands for neuronal nicotinic acetylcholine receptors 52
Synthesis and cytotoxicity evaluation of thiophene analogues of 1-methyl-2,3-bis(hydroxymethyl)benzo[g]indole bis[N-(2-propyl)carbamate] 51
Tricyclic pyrazole derivatives as cannabinoid receptor antagonist 51
Ossadiazoli ad attività antiproliferativa 50
Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 50
Development and characterization of novel cannabinoid derivatives based on diarylpyridazine scaffold. 50
I 3,6-diazabiciclo[3.1.1]eptani: una nuova serie di potenti agonisti per i recettori μ degli oppioidi 49
Pharmaceutical Compounds 48
Oxadiazoles having anti proliferative activity 48
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands 48
Sintesi di 1,10-fenantroline chirali a simmetria C2 derivati da monoterpeni naturali quali utili leganti per la catalisi asimmetrica 48
Design of a new class of chiral C2-symmetric dipyridylmethane ligands and their application in asymmetric catalysis 48
Oxadiazoles having antiproliferative activity 47
Manuale di chimica farmaceutica. Progettazione, meccanismo d'azione e metabolismo dei farmaci 47
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS 47
Novel diazabicycloalkane delta opioid agonists 47
Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzolglindazole-based ligands for cannabinoid receptors 46
Synthesis and anti-HIV-1 activity of new delavirdine analogues carrying arylpyrrole moieties 46
Synthesis and biological evaluation of novel CB2 ligands 46
Synthesis, modelling, and m-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes 45
Synthesis of biologically active bridged diazabicycloheptanes 45
Tricyclic pyrazoles Part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands 45
Tricyclic pyrazoles. part 1: Synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors 45
Pharmaceutical compounds 45
Synthesis and cytotoxicity of substituted 2-benzylnaphth[2,3-d]imidazoles 45
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors 44
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands 44
Synthesis and μ-opioid receptor affinity of fused .bicyclic analogues of N-3(9)-Arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes (DBNs) 43
Synthesis and pharmacological evaluation of novel 4-Alkyl-5-thien-2'-yl pyrazole carboxamides 43
3-(5-Phenyl[1,3,4]oxadiazol-2-yl)-1H-benzo]g]indole and related compounds: synthesis and cytotoxic acitivities 43
Ring-fused pyrazole derivates as ligands for cannabinoid receptors: synthesis and investigation of structure-activity relationships 42
Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives 42
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists 42
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 42
Pharmaceutical compounds 42
Tricyclic pyrazoles. Part 3. Synthesis, biological evaluation and molecular modelling of analogues of the cannabinoid antagonist NESS 0327 42
Tricyclic thienopyrazole derivatives as ligands for cannabinoid receptors: synthesis and biological evaluation 42
Pharmaceutical compounds 41
Different classes of CB2 Ligands Potentially Useful in the Treatment of Pain. 41
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as μ-opioid receptor agonists. Effects on μ-affinity of arylalkenyl chain modifications 40
Synthesis and tumor cell lines inhibition of 1,3,4.oxadiazoles linked to tricyclic pyrroles 40
RNA-viruses. Enzymatic and receptorial inhibitors. Research signpost keral, India, (RNA-viruses. Enzymatic and recptoral inhibitors. 39
Synthesis of chiral C2-symmetric 1,10-phenanthrolines from naturally occurring monoterpenes 39
Synthesis and analgesic-antiinflammatory activities of novel acylarylhydrazones with a 5-phenyl-4-R-3-pyrrolyl-acyl moiety 39
Tricyciclic Pyrazoles. Synthesis and bilogical evaluation of novel 4,5-dihydro-1H-6-oxa-cicloepta[1,2-c]pyrazole-based analogues of cannabinoid antagonist NESS-0327 39
Synthesis and μ-opioid receptor affinity of heteroaromatic analogues of N-3(9)-Arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes (DBNs) 39
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 39
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors 38
NESS06SM reduces body weight with an improved profile relative to SR141716A 38
Sintesi di nuovi diazatriciclodicani (DTDs). Effetto della variazione strutturale della catena cinnamilica sulla μ-affinità e sull’analgesia oppioide 38
Pharmaceutical compounds 38
Pharmaceutical compounds 37
Synthesis and application in asymmetric copper(I)-catalyzed allylic oxidation of a new chiral 1,10-phenantroline derived from pinene 37
Substituted 3,8-diazabicyclo[3.2.1]octane compounds 37
Sintesi di nuovi leganti chirali dipiridilmetanici e loro applicazione nella sostituzione allilica palladio-catalizzata 36
Myrtanil substituent in 3 position of pirazole ring determines CB1 agonism of novel 4,5-dihydrobenzo-oxa-cycloheptapyrazole cannabinoids 36
Versatility of the pyridazine system: chemistry and biology 36
Oxadiazoles having antiproliferative activity 35
Diazacyclic compounds having affinity for opioid receptors 35
Synthesis and cytotoxic activities of 3-(5-phenyl-[1.3.4]oxadiazol-2-yl)-1H-benzo[g]indole and related compounds 35
I farmaci antivirali. Dalla progettazione all’impiego terapeutico. 35
Chimica farmaceutica 35
Chimica farmaceutica. Con e-book 34
Sintesi e affinità per i recettori oppioidi di nuovi N3-propionil-N6-naftilprop(en)il-3,6-diazabiciclo[3.3.1]eptani 34
Pharmaceutical compounds 33
Pharmaceutical Compounds 33
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazoles: A versatile architecture for CB2 selective ligands 33
Synthesis, Pharmacological Evaluation and Docking Studies of Pyrrole Structure-Based CB2 Receptor Antagonists 33
Principi generali. In: Chimica Tossicologica 32
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 32
Tricyclic thieno-pyrazoles as new potent and selective CB2 ligands 32
Pyrazolo-naphthyridines: Design and Synthesis of potential CB-ligands 31
A survey of Recent Patents on CB2 Agonists in the Management of Pain 31
New tricyclic pyrazole derivatives as CB1 antagonists having improved activity towards food intake and weight control 30
Totale 4.637
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.101
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020916 0 3 106 7 103 188 218 15 126 38 109 3
2020/2021920 110 5 138 12 111 32 124 23 128 135 82 20
2021/2022572 67 6 9 7 8 5 28 48 51 37 61 245
2022/20231.271 130 78 27 229 110 210 2 161 228 8 56 32
2023/2024396 58 26 15 7 37 81 1 55 3 4 50 59
2024/202531 20 11 0 0 0 0 0 0 0 0 0 0
Totale 5.159